Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists

Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists Mastering tricyclic ring systems for desirable functional cannabinoid activity Novel 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New CB₂Cannabinoid Receptors Agonists:  Synthesis, Pharmacological Properties and Molecular Modeling Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB₂ Cannabinoid Receptor Partial Agonists 7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB₂Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands Novel benzimidazole derivatives as selective CB2 agonists